Mesa, Ruben A <br/><br/>
Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine.  [electronic resource] 

 -  Blood  Jul 2005 
 - 318-27 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2004-09-3523  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antimetabolites, Antineoplastic--pharmacology<br/>Benzoquinones<br/>Checkpoint Kinase 1<br/>Cytarabine--pharmacology<br/>Drug Synergism<br/>HL-60 Cells<br/>HSP90 Heat-Shock Proteins--antagonists & inhibitors<br/>Humans<br/>Lactams, Macrocyclic<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Protein Kinases--genetics<br/>RNA, Small Interfering<br/>Rifabutin--analogs & derivatives<br/>S Phase--drug effects